« Back
Home /
Riamilovir

Riamilovir

Item no.	TMO-T8904-25mg
Manufacturer	TargetMol
CASRN	123606-06-4
Amount	25 mg
Quantity options	100 mg 10 mg 1 mL 1 mg 25 mg 2 mg 50 mg 5 mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Purity	99.90%
Citations	Shahab S , Sheikhi M . Triazavirin - Potential Inhibitor for 2019-nCoV Coronavirus M Protease: A DFT Study[J]. Current Molecular Medicine, 2020.
Smiles	O=C1N2C(NC(SC)=N2)=NN=C1N(=O)=O
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	7-methylsulfanyl-3-nitro-6H-[1,2,4]triazolo[5,1-c][1,2,4]triazin-4-one, Triazavirin
Shipping condition	Cool pack
Available
Manufacturer - Targets	Antiviral
Shipping Temperature	cool pack
Storage Conditions	-20°
Molecular Weight	228, 19
Target names or alias	Triazavirin , 7-methylsulfanyl-3-nitro-6H-[1, 2, 4]triazolo[5, 1-c][1, 2, 4]triazin-4-one
Description	Riamilovir (7-methylsulfanyl-3-nitro-6H-[1, 2, 4]triazolo[5, 1-c][1, 2, 4]triazin-4-one) is a broad-spectrum antiviral drug candidate.
Pathways	Immunology/Inflammation

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T8904-25mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 25 mg

available

Request delivery time